Visceral Adipose Tissue-Directed FGF21 Gene Therapy Improves Metabolic and Immune Health in BTBR Mice

Title
Visceral Adipose Tissue-Directed FGF21 Gene Therapy Improves Metabolic and Immune Health in BTBR Mice
Authors
Keywords
FGF21, gene therapy, AAV, adeno-associated virus, adipose, visceral, adipose tissue macrophages, obesity, type 2 diabetes, fat
Journal
Publisher
Elsevier BV
Online
2020-12-25
DOI
10.1016/j.omtm.2020.12.011

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started